Ixekizumab Results in Persistent Clinical Improvement in Moderateto-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

por GUENTHER, Lyn, BLEAKMAN, Alison POTTS, WEISMAN, Jamie, POULIN, Yves, SPELMAN, Lynda, BURGE, Russel, ERICKSON, Janelle, TODD, Kristin, BERTRAM, Clinton C., RYAN, Caitriona
Publicado 2020

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)

por Chandran, Vinod, van der Heijde, Désirée, Fleischmann, Roy M, Lespessailles, Eric, Helliwell, Philip S, Kameda, Hideto, Burgos-Vargas, Ruben, Erickson, Janelle S, Rathmann, Suchitrita S, Sprabery, Aubrey Trevelin, Birt, Julie A, Shuler, Catherine L, Gallo, Gaia
Publicado 2020